242 related articles for article (PubMed ID: 24074647)
21. Whole-Body Low-Dose CT in Multiple Myeloma: Diagnostic Value of Appendicular Medullary Patterns of Attenuation.
Koutoulidis V; Terpos E; Klapa I; Cheliotis G; Ntanasis-Stathopoulos I; Boultadaki A; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
AJR Am J Roentgenol; 2021 Mar; 216(3):742-751. PubMed ID: 33439048
[No Abstract] [Full Text] [Related]
22. Vertebral lesion distribution in multiple myeloma--assessed by reduced-dose whole-body MDCT.
Bier G; Kloth C; Schabel C; Bongers M; Nikolaou K; Horger M
Skeletal Radiol; 2016 Jan; 45(1):127-33. PubMed ID: 26476728
[TBL] [Abstract][Full Text] [Related]
23. Automated "Bone Subtraction" Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma.
Horger M; Ditt H; Liao S; Weisel K; Fritz J; Thaiss WM; Kaufmann S; Nikolaou K; Kloth C
Acad Radiol; 2017 May; 24(5):623-632. PubMed ID: 28256439
[TBL] [Abstract][Full Text] [Related]
24. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.
Kröpil P; Fenk R; Fritz LB; Blondin D; Kobbe G; Mödder U; Cohnen M
Eur Radiol; 2008 Jan; 18(1):51-8. PubMed ID: 17924119
[TBL] [Abstract][Full Text] [Related]
25. Whole Body Low Dose Computed Tomography Using Third-Generation Dual-Source Multidetector With Spectral Shaping: Protocol Optimization and Literature Review.
Baldi D; Tramontano L; Alfano V; Punzo B; Cavaliere C; Salvatore M
Dose Response; 2020; 18(4):1559325820973131. PubMed ID: 33456411
[TBL] [Abstract][Full Text] [Related]
26. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.
Horger M; Kanz L; Denecke B; Vonthein R; Pereira P; Claussen CD; Driessen C
Cancer; 2007 Apr; 109(8):1617-26. PubMed ID: 17330855
[TBL] [Abstract][Full Text] [Related]
27. Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies.
Minarik J; Krhovska P; Hrbek J; Pika T; Bacovsky J; Herman M; Scudla V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):305-9. PubMed ID: 26740048
[TBL] [Abstract][Full Text] [Related]
28. Value of FDG PET in the assessment of patients with multiple myeloma.
Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
[TBL] [Abstract][Full Text] [Related]
29. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
30. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
Bäuerle T; Hillengass J; Fechtner K; Zechmann CM; Grenacher L; Moehler TM; Christiane H; Wagner-Gund B; Neben K; Kauczor HU; Goldschmidt H; Delorme S
Radiology; 2009 Aug; 252(2):477-85. PubMed ID: 19703885
[TBL] [Abstract][Full Text] [Related]
31. Imaging in multiple myeloma: How? When?
Zamagni E; Tacchetti P; Cavo M
Blood; 2019 Feb; 133(7):644-651. PubMed ID: 30587527
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
33. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
34. [Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].
Baur-Melnyk A; Reiser M
Radiologe; 2004 Sep; 44(9):874-81. PubMed ID: 15365631
[TBL] [Abstract][Full Text] [Related]
35. Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group.
Moulopoulos LA; Koutoulidis V; Hillengass J; Zamagni E; Aquerreta JD; Roche CL; Lentzsch S; Moreau P; Cavo M; Miguel JS; Dimopoulos MA; Rajkumar SV; Durie BGM; Terpos E; Delorme S
Blood Cancer J; 2018 Oct; 8(10):95. PubMed ID: 30287814
[TBL] [Abstract][Full Text] [Related]
36. [Bone disease in multiple myeloma. A study of 237 cases].
Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
[TBL] [Abstract][Full Text] [Related]
37. Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging.
Treitl KM; Ricke J; Baur-Melnyk A
Skeletal Radiol; 2022 Jan; 51(1):43-58. PubMed ID: 34031705
[TBL] [Abstract][Full Text] [Related]
38. Patient dose evaluation for the whole-body low-dose multidetector CT (WBLDMDCT) skeleton study in multiple myeloma (MM).
Cretti F; Perugini G
Radiol Med; 2016 Feb; 121(2):93-105. PubMed ID: 26286004
[TBL] [Abstract][Full Text] [Related]
39. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
